Identification of novel indicators of cyclosporine A nephrotoxicity in a CD-1 mouse model

Toxicology and Applied Pharmacology

Volumn 252, Issue 2, 2011, Pages 201-210

  O'Connell, Séin ^a   Slattery, Craig ^a   Ryan, Michael P ^a   McMorrow, Tara ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cadherin 1 (CDH 1); Connective tissue growth factor; Fibroblast specific protein 1; Transforming growth factor beta 1 and 2 DE

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CADHERIN; CADHERIN 1; CALVASCULIN; CREATININE; CYCLOSPORIN A; PODOCIN; SUPEROXIDE DISMUTASE; TAMM HORSFALL GLYCOPROTEIN; UNCLASSIFIED DRUG; VINCULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MARKER; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY PARENCHYMA; MALE; MOUSE; NEPHRON; NEPHROTOXICITY; NONHUMAN; PROTEINURIA; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; CYCLOSPORINE; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, MEMBRANOUS; KIDNEY; MALE; MICE; NEPHRITIS;

MURINAE; MUS;

EID: 79953677776     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.02.015     Document Type: Article

References (55)

1. Bestard O., Cruzado J.M., Grinyo J.M. Calcineurin-inhibitor-sparing immunosuppressive protocols. Transplant. Proc. 2005, 37:3729-3732.
2. Bobadilla N.A., Gamba G. New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone. Am. J. Physiol. Renal Physiol. 2007, 293:F2-F9.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
4. Chaaya R., Alfarano C., Guilbeau-Frugier C., Coatrieux C., Kesteman A.S., Parini A., Fares N., Gue M., Schanstra J.P., Bascands J.L. Pargyline reduces renal damage associated with ischaemia-reperfusion and cyclosporin. Nephrol. Dial. Transplant. 2011, 26:489-498.
5. Clarke H., Ryan M.P. Cyclosporine A-induced alterations in magnesium homeostasis in the rat. Life Sci. 1999, 64:1295-1306.
6. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
7. Dieterle F., Perentes E., Cordier A., Roth D.R., Verdes P., Grenet O., Pantano S., Moulin P., Wahl D., Mahl A., End P., Staedtler F., Legay F., Carl K., Laurie D., Chibout S.D., Vonderscher J., Maurer G. Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat. Biotechnol. 2010, 28:463-469.
8. Dudas P.L., Argentieri R.L., Farrell F.X. BMP-7 fails to attenuate TGF-beta1-induced epithelial-to-mesenchymal transition in human proximal tubule epithelial cells. Nephrol. Dial. Transplant. 2009, 24:1406-1416.
9. El Chaar M., Chen J., Seshan S.V., Jha S., Richardson I., Ledbetter S.R., Vaughan E.D., Poppas D.P., Felsen D. Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction. Am. J. Physiol. Renal Physiol. 2007, 292:F1291-F1301.
10. Feighery R., Maguire T., Ryan M.P., McMorrow T. A proteomic approach to immune-mediated epithelial-mesenchymal transition. Proteomics Clin. Appl. 2008, 2:1110-1117.
11. Gaston R.S. Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm. Clin. J. Am. Soc. Nephrol. 2009, 4:2029-2034.
12. Grotendorst G.R. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 1997, 8:171-179.
13. Gupta S., Clarkson M.R., Duggan J., Brady H.R. Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int. 2000, 58:1389-1399.
14. Hara S., Umino D., Someya T., Fujinaga S., Ohtomo Y., Murakami H., Shimizu T. Protective effects of Mizoribine on Cyclosporine A nephropathy in rats. Pediatr. Res. 2009, 66:524-527.
15. Hession C., Decker J.M., Sherblom A.P., Kumar S., Yue C.C., Mattaliano R.J., Tizard R., Kawashima E., Schmeissner U., Heletky S., et al. Uromodulin (Tamm-Horsfall glycoprotein): a renal ligand for lymphokines. Science 1987, 237:1479-1484.
16. Huber T.B., Kottgen M., Schilling B., Walz G., Benzing T. Interaction with podocin facilitates nephrin signaling. J. Biol. Chem. 2001, 276:41543-41546.
17. Ito Y., Aten J., Bende R.J., Oemar B.S., Rabelink T.J., Weening J.J., Goldschmeding R. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int. 1998, 53:853-861.
18. Jia J., Wang J., Teh M., Sun W., Zhang J., Kee I., Chow P.K., Liang R.C., Chung M.C., Ge R. Identification of proteins differentially expressed between capillary endothelial cells of hepatocellular carcinoma and normal liver in an orthotopic rat tumor model using 2-D DIGE. Proteomics 2010, 10:224-234.
19. Jiang H., Guan G., Zhang R., Liu G., Cheng J., Hou X., Cui Y. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. Diabetes Metab. Res. Rev. 2009, 25:232-241.
20. Kaden J., Oesterwitz H., May G., Strobelt V., Schroder K., Bohnke C., Gellert S., Groth J., Schabel J., Eismann R., Templin R., Sehland J. Effects of PUVA therapy on kidney allografts: results of a randomized prospective double-blind study. Transpl. Int. 1994, 7(Suppl 1):S275-S280.
21. Kattla J.J., Carew R.M., Heljic M., Godson C., Brazil D.P. Protein kinase B/Akt activity is involved in renal TGF-beta1-driven epithelial-mesenchymal transition in vitro and in vivo. Am. J. Physiol. Renal Physiol. 2008, 295:F215-F225.
22. Kiely B., Feldman G., Ryan M.P. Modulation of renal epithelial barrier function by mitogen-activated protein kinases (MAPKs): mechanism of cyclosporine A-induced increase in transepithelial resistance. Kidney Int. 2003, 63:908-916.
23. Kistler A.D., Mischak H., Poster D., Dakna M., Wuthrich R.P., Serra A.L. Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease. Kidney Int. 2009, 76:89-96.
24. Kwong Y.T., Stevens L.A., Selvin E., Zhang Y.L., Greene T., Van Lente F., Levey A.S., Coresh J. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Am. J. Kidney Dis. 2010, 56:39-49.
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
26. Lan H.Y. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr. Opin. Nephrol. Hypertens. 2003, 12:25-29.
27. Li C., Yang C.W. The pathogenesis and treatment of chronic allograft nephropathy. Nat. Rev. Nephrol. 2009, 5:513-519.
28. Ling H., Li X., Jha S., Wang W., Karetskaya L., Pratt B., Ledbetter S. Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation. J. Am. Soc. Nephrol. 2003, 14:377-388.
29. Lloberas N., Torras J., Alperovich G., Cruzado J.M., Gimenez-Bonafe P., Herrero-Fresneda I., Franquesa M., Rama I., Grinyo J.M. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats. Nephrol. Dial. Transplant. 2008, 23:3111-3119.
30. Macconi D., Sangalli F., Bonomelli M., Conti S., Condorelli L., Gagliardini E., Remuzzi G., Remuzzi A. Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition. Am. J. Pathol. 2009, 174:797-807.
31. Martin-Martin N., Ryan G., McMorrow T., Ryan M.P. Sirolimus and cyclosporine A alter barrier function in renal proximal tubular cells through stimulation of ERK1/2 signaling and claudin-1 expression. Am. J. Physiol. Renal Physiol. 2010, 298:F672-F682.
32. McMorrow T., Gaffney M.M., Slattery C., Campbell E., Ryan M.P. Cyclosporine A induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. Nephrol. Dial. Transplant. 2005, 20:2215-2225.
33. Murphy M., Godson C., Cannon S., Kato S., Mackenzie H.S., Martin F., Brady H.R. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J. Biol. Chem. 1999, 274:5830-5834.
34. Phanish M.K., Winn S.K., Dockrell M.E. Connective tissue growth factor-(CTGF, CCN2)-a marker, mediator and therapeutic target for renal fibrosis. Nephron Exp. Nephrol. 2010, 114:e83-e92.
35. Prajczer S., Heidenreich U., Pfaller W., Kotanko P., Lhotta K., Jennings P. Evidence for a role of uromodulin in chronic kidney disease progression. Nephrol. Dial. Transplant. 2010, 25:1896-1903.
36. Qi W., Chen X., Poronnik P., Pollock C.A. The renal cortical fibroblast in renal tubulointerstitial fibrosis. Int. J. Biochem. Cell Biol. 2006, 38:1-5.
37. Rastaldi M.P., Ferrario F., Giardino L., Dell'Antonio G., Grillo C., Grillo P., Strutz F., Muller G.A., Colasanti G., D'Amico G. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int. 2002, 62:137-146.
38. Reis F.N. The unsolved cyclosporine-induced kidney injury: is paricalcitol a feasible new renoprotective option?. Kidney Int. 2010, 77:1055-1057.
39. Rosenkranz M.E., Wilson D.C., Marinov A.D., Decewicz A., Grof-Tisza P., Kirchner D., Giles B., Reynolds P.R., Kolli K., Thompson S.D., Hirsch R. Synovial fluid proteins differentiate between the subtypes of juvenile idiopathic arthritis. Arthrit. Rheum. 2010, 62(6):1813-1823.
40. Sakairi T., Abe Y., Kajiyama H., Bartlett L.D., Howard L.V., Jat P.S., Kopp J.B. Conditionally immortalized human podocyte cell lines established from urine. Am. J. Physiol. Renal Physiol. 2010, 298:F557-F567.
41. Sato Y., Wharram B.L., Lee S.K., Wickman L., Goyal M., Venkatareddy M., Chang J.W., Wiggins J.E., Lienczewski C., Kretzler M., Wiggins R.C. Urine podocyte mRNAs mark progression of renal disease. J. Am. Soc. Nephrol. 2009, 20:1041-1052.
42. Shihab F.S., Bennett W.M., Yi H., Choi S.O., Andoh T.F. Mycophenolate mofetil ameliorates arteriolopathy and decreases transforming growth factor-beta1 in chronic cyclosporine nephrotoxicity. Am. J. Transplant. 2003, 3:1550-1559.
43. Shihab F.S., Bennett W.M., Yi H., Andoh T.F. Effect of cyclosporine and sirolimus on the expression of connective tissue growth factor in rat experimental chronic nephrotoxicity. Am. J. Nephrol. 2006, 26:400-407.
44. Slattery C., Campbell E., McMorrow T., Ryan M.P. Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition. Am. J. Pathol. 2005, 167:395-407.
45. Slattery C., McMorrow T., Ryan M.P. Overexpression of E2A proteins induces epithelial-mesenchymal transition in human renal proximal tubular epithelial cells suggesting a potential role in renal fibrosis. FEBS Lett. 2006, 580:4021-4030.
46. Thomas S.E., Andoh T.F., Pichler R.H., Shankland S.J., Couser W.G., Bennett W.M., Johnson R.J. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int. 1998, 53:897-908.
47. Tuglular S., Gogas Yavuz D., Cakalagaoglu F., Citak L., Arikan H., Kocak H., Ozener C., Akoglu E. Cyclosporine-A induced nephrotoxicity is associated with decreased renal bone morphogenetic protein-7 expression in rats. Transplant. Proc. 2004, 36:131-133.
48. Turk T., Leeuwis J.W., Gray J., Torti S.V., Lyons K.M., Nguyen T.Q., Goldschmeding R. BMP signaling and podocyte markers are decreased in human diabetic nephropathy in association with CTGF overexpression. J. Histochem. Cytochem. 2009, 57:623-631.
49. Veerasamy M., Nguyen T.Q., Motazed R., Pearson A.L., Goldschmeding R., Dockrell M.E. Differential regulation of E-cadherin and alpha-smooth muscle actin by BMP 7 in human renal proximal tubule epithelial cells and its implication in renal fibrosis. Am. J. Physiol. Renal Physiol. 2009, 297:F1238-F1248.
50. Wang S., Hirschberg R. BMP7 antagonizes TGF-beta-dependent fibrogenesis in mesangial cells. Am. J. Physiol. Renal Physiol. 2003, 284:F1006-F1013.
51. Wang G., Lai F.M., Kwan B.C., Lai K.B., Chow K.M., Li P.K., Szeto C.C. Podocyte loss in human hypertensive nephrosclerosis. Am. J. Hypertens. 2009, 22:300-306.
52. Xu Y., Wan J., Jiang D., Wu X. BMP-7 blocks the cyclosporine-A-induced epithelial-to-mesenchymal transition in renal tubular epithelial cells. Nephron Exp. Nephrol. 2009, 114:e23-e31.
53. Yang C.W., Faulkner G.R., Wahba I.M., Christianson T.A., Bagby G.C., Jin D.C., Abboud H.E., Andoh T.F., Bennett W.M. Expression of apoptosis-related genes in chronic cyclosporine nephrotoxicity in mice. Am. J. Transplant. 2002, 2:391-399.
54. Yokoi H., Mukoyama M., Sugawara A., Mori K., Nagae T., Makino H., Suganami T., Yahata K., Fujinaga Y., Tanaka I., Nakao K. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am. J. Physiol. Renal Physiol. 2002, 282:F933-F942.
55. Zeisberg M., Hanai J., Sugimoto H., Mammoto T., Charytan D., Strutz F., Kalluri R. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 2003, 9:964-968.